Literature DB >> 3760245

Pharmacokinetics of diphenhydramine and a demethylated metabolite following intravenous and oral administration.

G T Blyden, D J Greenblatt, J M Scavone, R I Shader.   

Abstract

Ten healthy volunteers received a single 50-mg dose of diphenhydramine (DP) hydrochloride intravenously and orally on two separate occasions. Kinetics of DP and a major demethylated metabolite (DMDP) were determined from multiple plasma samples drawn during a 24- to 48-hour period after dosage. Modification of a gas chromatographic (GC) technique allowed simultaneous quantitation of DP and DMDP. Mean kinetic variables for DP after intravenous (IV) dosage were: volume of distribution, 4.5 L/kg; elimination half-life, 8.4 hours; clearance, 6.2 mL/min/kg. After oral DP administration, a peak plasma level of 66 ng/mL was reached 2.3 hours after dosage. Systemic availability was 72%, nearly identical to the predicted estimate (71%) based on clearance of IV DP relative to hepatic blood flow. Appearance of the metabolite, DMDP, mirrored disappearance of DP; the area under the plasma concentration-time curve (AUC) for DMDP was highly correlated (r = .79, P less than .05) with a clearance of IV DP. However, metabolite AUC was significantly higher after oral as opposed to IV DP (218 vs 145 hr-ng/mL, P less than .05). Because DP and DMDP elute nearly identically on standard GC systems, methodologic modifications are needed to resolve them. Coelution of the two compounds could bias kinetic data based on plasma concentration presumed to be specific for intact DP.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3760245     DOI: 10.1002/j.1552-4604.1986.tb02946.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  26 in total

1.  Sleep Health and Appropriate Use of OTC Sleep Aids in Older Adults-Recommendations of a Gerontological Society of America Workgroup.

Authors:  Steven M Albert; Thomas Roth; Michael Toscani; Michael V Vitiello; Phyllis Zee
Journal:  Gerontologist       Date:  2015-10-28

2.  Common drugs inhibit human organic cation transporter 1 (OCT1)-mediated neurotransmitter uptake.

Authors:  Kelli H Boxberger; Bruno Hagenbuch; Jed N Lampe
Journal:  Drug Metab Dispos       Date:  2014-03-31       Impact factor: 3.922

3.  Relationship between sedation and pupillary function: comparison of diazepam and diphenhydramine.

Authors:  Ruihua H Hou; Jessica Scaife; Clare Freeman; Rob W Langley; Elemer Szabadi; Chris M Bradshaw
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

4.  Use of metabolite AUC data in bioavailability studies to discriminate between absorption and first-pass extraction.

Authors:  M Weiss
Journal:  Clin Pharmacokinet       Date:  1990-05       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors:  J M Cedarbaum
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

Review 6.  Predictive Value of Microdose Pharmacokinetics.

Authors:  Merel van Nuland; Hilde Rosing; Alwin D R Huitema; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2019-10       Impact factor: 6.447

7.  Effects of diphenhydramine on human eye movements.

Authors:  J R Hopfenbeck; D S Cowley; A Radant; D J Greenblatt; P P Roy-Byrne
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

8.  Frequent occurrence of hypophosphatemia among multiple myeloma patients treated with elotuzumab: a single clinic retrospective study.

Authors:  Bernard Regidor; Regina Swift; Benjamin Eades; Marsiye Emamy-Sadr; Fadi Tarhini; Tanya M Spektor; James R Berenson
Journal:  Ann Hematol       Date:  2020-11-25       Impact factor: 3.673

9.  Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.

Authors:  Shu-Feng Zhou
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

10.  Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine.

Authors:  J M P Baas; N Mol; J L Kenemans; E P Prinssen; I Niklson; C Xia-Chen; F Broeyer; J van Gerven
Journal:  Psychopharmacology (Berl)       Date:  2009-05-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.